BioCentury
ARTICLE | Company News

Geron, Infigen gene/cell therapy news

January 19, 2004 8:00 AM UTC

GERN said the U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences ruled that claims of Infigen's patent application for animal cloning technology are unpatentable. The interfe...